Cargando…
Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients’ Clinical Features
BACKGROUND: The aim of this study was to determine the expression of EGFR/HER-2 and investigate their association with patients’ clinical features in bladder transitional cell carcinoma (BTCC). MATERIAL/METHODS: Immunohistochemistry was utilized in our study to explore the expression of EGFR/HER-2 o...
Autores principales: | Li, Wei, Wang, Youquan, Tan, Shubo, Rao, Qishuo, Zhu, Tian, Huang, Guo, Li, Zhuo, Liu, Guowen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190725/ https://www.ncbi.nlm.nih.gov/pubmed/30296252 http://dx.doi.org/10.12659/MSM.911640 |
Ejemplares similares
-
Lapatinib, a Dual Inhibitor of Epidermal Growth Factor Receptor (EGFR) and HER-2, Enhances Radiosensitivity in Mouse Bladder Tumor Line-2 (MBT-2) Cells In Vitro and In Vivo
por: Mu, Yi, et al.
Publicado: (2018) -
Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells
por: Li, Dapeng, et al.
Publicado: (2018) -
Butein Inhibited In Vitro Hexokinase-2-Mediated Tumor Glycolysis in Hepatocellular Carcinoma by Blocking Epidermal Growth Factor Receptor (EGFR)
por: Liao, Weirong, et al.
Publicado: (2018) -
Inhibition of Epidermal Growth Factor Receptor (EGFR) Reduces Lipopolysaccharide (LPS)-Induced Activation and Inflammatory Cytokines in Hepatic Stellate Cells In Vitro
por: Qian, Yuanyuan, et al.
Publicado: (2018) -
Honokiol Suppression of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastric Cancer Cell Biological Activity and Its Mechanism
por: Yan, Yidan, et al.
Publicado: (2020)